Company type | Private |
---|---|
Industry | Pharmaceuticals |
Founded | 9 March 1908 |
Founder | Friedrich Merz |
Headquarters | Frankfurt am Main, |
Key people |
|
Revenue | EUR 1.3434 billion (2021/22) |
Number of employees | 3,730 (2021/22) |
Website | www |
Merz Pharma GmbH & Co. KGaA (also Merz Pharma KGaA or Merz) is an internationally active family-owned company, headquartered in Frankfurt am Main, Germany. Merz is the parent company of independent businesses in the fields of aesthetic medicine, therapeutic medicine (including for neurological movement disorders), and wellness and beauty products with its brands Tetesept [1] and Merz Spezial. [2]
The company was founded by Friedrich Merz and is still family-owned. [3] The management consists of Philip Burchard and Hans-Jörg Bergler. [4]
Merz Pharma GmbH & Co. KGaA is the parent company of the Merz Group. Since the 2020/21 financial year, the group has controlled the three businesses Merz Aesthetics GmbH, Merz Therapeutics GmbH and Merz Consumer Care GmbH. The businesses are under the supervision of the Merz board of partners and the Merz supervisory board. [5]
Merz employs around 3,730 people (2021/22) and generated a revenue of EUR 1.3434 billion in the 2021/22 fiscal year. [6] A large part of the revenue is generated in the United States through the sale of special products for medical and aesthetic applications. [7] Approximately 45% of sales are generated in the United States and almost 80% of all sales are generated outside of Germany. [8]
Merz manages three production sites in Reinheim and Dessau (Germany) as well as in Racine County, Wisconsin (USA). [9] In addition, the Group has its own sales offices in Brazil, France, Great Britain, Italy, Canada, South Korea, Mexico, Austria, Russia, Switzerland, Singapore, Spain, Taiwan, USA, [9] Argentina, Australia, China, Hong Kong, India, Indonesia, Colombia, the Netherlands, Thailand, Malaysia, the Philippines, the United Arab Emirates and Vietnam. In addition, the group is active in around 70 countries through cooperations and distribution partnerships. [5]
Merz Aesthetics develops and sells products in the field of aesthetic medicine, e.g. a botulinum toxin, dermal fillers or medical technology. [10] It is the world's largest company dedicated exclusively to medical aesthetics. Bob Rhatigan manages this business as CEO. [11]
Merz Aresthetics uses celebrities to market its products. In 2019, model Christie Brinkley promoted a non-invasive wrinkle-tightening procedure. Gwyneth Paltrow became the first brand ambassador for Merz Aesthetics in 2020. [12] In 2023, Christina Aguilera promoted anti-wrinkle injections. [13] The company is also primary sponsor for the North Carolina Courage. [14]
Merz announced his first three ambassadors for the Asia-Pacific region in 2022; korean celebrities Lee Min-ho, Kim Ha-neul and Jeon So-min. [15]
Merz Therapeutics develops and distributes products for the treatment of neurological movement disorders such as dystonia and spasticity. It has its headquarters in Frankfurt. [16] Stefan König has been the managing director of this division since 2023. [16] In 2024, Merz Therapeutics acquired Inbrija, an inhaled Parkinson’s disease medication, and Ampyra (also known as Fampyra in some markets), a sustained-release multiple sclerosis tablet for $185 million from Acorda Therapeutics, which had filed for bankruptcy. [17]
Merz Consumer Care develops and distributes health, beauty, and wellness products. The main brands are tetesept and Merz Spezial. It has its headquarters in Frankfurt. [18] Xenia Barth has been the managing director of this division since 2022. [19] In May 2023, the name Merz Lifecare was introduced as the corporate brand instead of Merz Consumer Care. Merz Consumer Care GmbH has been retained as the company name. [20]
In 1908, the trained pharmacist and chemist Friedrich Merz set up his own pharmaceutical production in Frankfurt am Main. At the time of its foundation, Merz already held a patent and a utility model protection. The company subsequently expanded and one year later moved to a former cigarette factory, [9] where the company's headquarters have been located since. [3] [9] In the beginning, Merz developed and produced the first contraceptive for birth control, as well as menthol refreshment cigarettes, and ointments against scaly skin. During the Second World War, Allied air raids on Frankfurt destroyed about 70% of the buildings. However, Merz had outsourced duplicates of its production machinery to Reinheim (Darmstadt) and was thus able to quickly rebuild production after the end of the war. [7]
In 1953, Merz entered the cosmetics business with the first anti-wrinkle product (Placentubex). From the 1960s onwards, Merz developed dragées for beauty care. [21] Merz Spezial Dragees came into the market in 1964 and were promoted in the 1970s and 1980s under the slogan "Natural beauty comes from within". [22] [23] In the 1970s, the company also expanded its products for medical prescription, for example for the treatment of Parkinson's disease and lowering elevated blood lipids. In 2002, Merz developed Memantine, the world's first active ingredient for the treatment of moderate to severe Alzheimer's dementia. [21] In 2005, Merz brought a new generation of botulinum toxins into the market. [9] At that time, the preparation was the only botulinum toxin type A (BoNT/A) without complexing foreign proteins and thus reduced the risk of antibody-mediated therapy failure. [24]
In 2012, the previous managing director and grandson of the company founder, Jochen Hückmann, retired from the business and handed over the management to Burchard. [3] Hückmann had held the management since the early 1970s. During this time, the company continued to expand its position internationally among other things with the development of the active ingredient Memantine. [21]
The patent for Memantine expired in Germany in 2012. Until then, it was the only approved drug against moderate and severe forms of dementia. In the USA, the drug still had three years of patent protection. In order not to suffer a drop in sales after the patent expired, the expansion of the aesthetic and special neurology divisions was pushed ahead. [3] [21] Three years earlier, Merz had acquired the US company Bioform Medical for EUR 190 million. Bioform specialised in the production of fillers for aesthetic medicine. [3]
This was followed in 2013 by the purchase of the Swiss company Neocutis, whose aesthetic dermatology products were mainly in the USA by physicians. In the same year Merz took over the Swiss company Anteis, which also produced fillers for aesthetic medicine. Merz entered the non-invasive facelift medical device business in 2014 with the acquisition of US company Ulthera for a sum close to $600 million. [25] [26] [27] In 2015 Merz launched a subsidiary in Thailand. [28]
Merz established a new corporate structure in late 2020. This organisational structure consists of three independently operating business divisions: Merz Aesthetics, Merz Therapeutics and Merz Consumer Care. In addition, the global Merz Aesthetics team moved from Frankfurt to Raleigh, North Carolina. [5] [29] In early 2020, the company's business collapsed for three months as a result of the initial impact of the COVID-19 pandemic. Cosmetic and medical procedures were cancelled due to fear of contracting the virus and the scarcity of personal protective equipment such as gloves. [11]
It was announced at the beginning of 2023 that Merz would invest around EUR 120 million in the Reinheim site and that production at the site between the old town and the Gersprenzauen meadows would be phased out. [30]
The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies globally.
Braun GmbH is a German consumer products company founded in 1921 and based in Kronberg im Taunus. The company is known for its design aesthetic from the 1960s through the 1980s, which included products such as electric shavers, radiograms and record players, movie cameras, slide projectors, clocks, and small kitchen appliances for which "Braun became shorthand for reliable, no-nonsense modernist goods."
Memantine, sold under the brand name Namenda among others, is a medication used to slow the progression of moderate-to-severe Alzheimer's disease. It is taken by mouth.
Fresenius SE & Co. KGaA is a European multinational health care company based in Bad Homburg vor der Höhe, Germany. It provides products and services for dialysis in hospitals, as well as inpatient and outpatient medical care. The company is involved in hospital management and in engineering and services for medical centers and other health care facilities.
Heraeus is a German technology group with a focus on precious and special metals, medical technology, quartz glass and sensors as well as electronic components. Founded in Hanau in 1851, the company is one of the largest family-owned companies in Germany in terms of revenue. Heraeus employs 16,400 people in 40 countries and generated a total revenue of €25.6 billion in 2023. The headquarters and head office are in Hanau, Germany.
Schleich is a German producer of hand painted toy figurines and accessories. The company is headquartered in Schwäbisch Gmünd, Germany. In 2020, the group employed 440 people and generated sales of 188.7 million euros. Half of the sales are generated outside of the German domestic market, and Schleich branded play figurines and playsets are sold in over 60 countries. In 2022, the company sold a total of approximately 40 million figurines.
Wera Tools is the popular name for tool manufacturer Wera Werkzeuge GmbH with headquarters in Cronenberg and production in Bystřice nad Pernštejnem and Třebíč in the Czech Republic.
J. Schmalz GmbH is a manufacturer of automation technology based in Glatten, Germany. The family-run company is one of the leading suppliers of vacuum technology in the fields of automation and manual handling and is also active in the energy storage business area. Over the years, the company's products changed from razor blades to transport equipment and finally to vacuum technology.
Bayer AG is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies and biomedical companies in the world. Headquartered in Leverkusen, Bayer's areas of business include: pharmaceuticals, consumer healthcare products, agricultural chemicals, seeds and biotechnology products. The company is a component of the EURO STOXX 50 stock market index.
Utimaco is a company active in the sector of cybersecurity and compliance solutions, with headquarters in Aachen, Germany, and Campbell, California, USA. Founded in 1983, the company provides on-premises and cloud-based hardware security modules, key management, data protection as well as data intelligence solutions for regulated critical infrastructures and Public Warning Systems.
Vetter Pharma-Fertigung GmbH & Co. KG is a German pharmaceutical service provider founded in 1950. It is headquartered in Ravensburg, Baden-Württemberg, and has production sites in Germany, Austria, the United States, as well as sales offices in Singapore, Japan, and South Korea. The company develops, manufactures and packages aseptically prefilled syringes, cartridges, and vials.
SYNLAB Group is an international medical diagnostics provider headquartered in Munich, Germany. SYNLAB is leading in diagnostic services and specialty testing in Europe.
Deutsche Leasing AG (DL) is a manufacturer-independent leasing company in Germany. Since 1987, the company has had its headquarters in Bad Homburg vor der Höhe and is the main leasing partner for the Sparkassen-Finanzgruppe. Shares are held by approximately 350 Sparkassen, either directly or indirectly through holding companies. Deutsche Leasing is the sole shareholder of Deutsche Anlagen-Leasing in Wiesbaden.
Lohmann & Rauscher (L&R) is an international developer, producer, and seller of medical devices and hygiene products - becoming globablly known as a leading supplier in these fields. The company is a result of a merger in 1998 between companies Lohmann and Rauscher, renamed as Lohmann & Rauscher International GmbH & Co. KG, with headquarters based in both Rengsdorf and Vienna.
Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. The company is the maker of Botox.
Batschkapp is a rock and pop concert venue in Frankfurt am Main. It is located in the warehouse district of the neighborhood of Seckbach, on Gwinnerstraße.
Meggle is a German milk and whey processing company based in Wasserburg am Inn.
Cheplapharm Arzneimittel GmbH, headquartered in Greifswald, is a German pharmaceutical company that markets branded drugs, medical products, supplements and cosmetics.
Wörwag Pharma is a medium-sized family-owned pharmaceutical company headquartered in Böblingen, Germany with subsidiaries in Asia, Europe and South America. It was founded in 1971 by pharmacist Fritz Wörwag in Stuttgart. It sells prescription and over-the-counter preparations and food supplements.
Schott Pharma is a provider of drug containment solutions and delivery systems for injectable drugs. Originally a division of glass manufacturer Schott AG, the company went public on the Frankfurt Stock Exchange in 2023. Headquartered in Mainz, Germany, the company operates in 14 countries.